Can we measure effectiveness of new cystic fibrosis treatments in improving lung health in children with cystic fibrosis aged less than 2 years of age during clinical trials conducted for the approval of new medicines?
A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis
